Axsome Therapeutics to report Q2 2026 results on August 10
Axsome Therapeutics will announce its Q2 2026 financial results on August 10, 2026, followed by a conference call at 8:00 a.m. ET. The call will cover the results and a business update, with a replay available on the company's website for 30 days.
*this image is generated using AI for illustrative purposes only.
Axsome Therapeutics, Inc. will report its financial results for the second quarter of 2026 on Monday, August 10, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update.
Conference Call Details
Investors can participate in the live call by dialing (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international). A live webcast will be accessible on the "Webcasts & Presentations" page under the "Investors" section of the company's website at www.axsome.com . A replay of the call will be available on the website for approximately 30 days following the event.
About Axsome Therapeutics
Axsome Therapeutics is a biopharmaceutical company focused on developing treatments for central nervous system (CNS) disorders. Its portfolio includes FDA-approved treatments for major depressive disorder, agitation associated with dementia due to Alzheimer’s disease, excessive daytime sleepiness associated with narcolepsy and obstructive sleep apnea, and migraine. The company also has multiple early- to late-stage development programs addressing serious neurological and psychiatric conditions.
What key performance indicators will investors focus on during Axsome's Q2 2026 earnings call?
How might Axsome's pipeline advancements impact its stock performance post-earnings?
What potential market expansions or new indications could Axsome announce during the business update?
16
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
